EUVIMEDEUVIMED entdecken
Fallbericht

Assessment of the status of DNA mismatch repair proteins by immunohistochemistry. Proposal for evaluation with two antibodies

Leonardo Saul Lino-Silva, Ángeles Galán-Ramírez, Sabrina B Martínez-Villavicencio, Luisa Rivera-Moncada, César Zepeda-Najar, Hanna I Ortega-Martínez

Polish Journal of Pathology · 13.03.2025 · 76 (1) · 54-58

DOI: 10.5114/pjp.2025.148390 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Polish Journal of Pathology, online erschienen am 13.03.2025. Verfasst von Leonardo Saul Lino-Silva und 5 weiteren Autor:innen. Beteiligte Einrichtung: Instituto Nacional De Cancerologia De Mèxico, Mexico City, Mexico. Hauptthemen laut MEDLINE: DNA Mismatch Repair, Mismatch Repair Endonuclease PMS2, Immunohistochemistry, Biomarkers, Tumor. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 16 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Determining the status of DNA mismatch repair (MMR) proteins is crucial for patients because they may respond differently to specific treatments and have a better prognosis. We proposed a panel with only 2 antibodies to determine the status of the MMR proteins, improving costs, workload, and delivery of results. Patients with adenocarcinoma and MMR determination were reclassified using only the evaluation of PMS2 and MSH6. The diagnostic performance of the 2-antibody test (proposed panel) and 4-antibody (traditional panel) test was compared against the polymerase chain reaction study (reference standard). A total of 202 cases were identified. The predominant histological type was adenocarcinoma not otherwise specified, the predominant histological grade was 2, and 60.9% of the cases were found in clinical stage II. When comparing the diagnostic performance of the traditional panel of 4 antibodies against a panel of 2 antibodies, no statistically significant differences were found (sensitivity 95.35% vs. 90.7%; specificity 98.74% vs. 98.11%; positive predictive value 95.35% vs. 92.86%; negative predictive value 98.74% vs. 97.50%; area under the curve 0.970 vs. 0.944; p = 0.419).Analysis of MMR status determination with only 2 antibodies demonstrates that it is as effective as using 4 antibodies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA Mismatch RepairMismatch Repair Endonuclease PMS2ImmunohistochemistryBiomarkers, TumorDNA-Binding ProteinsAdenocarcinomaColorectal NeoplasmsHumansFemaleMaleMiddle AgedAgedAdultAged, 80 and overAntibodiesPredictive Value of Tests

Stichwörter der Autor:innen

adenocarcinomacolon cancerdiagnostic performancemismatch repairmicrosatellite instability

Substanzen

Mismatch Repair Endonuclease PMS2PMS2 protein, humanBiomarkers, TumorDNA-Binding ProteinsG-T mismatch-binding proteinAntibodies

Autor:innen und Institutionen

  • Instituto Nacional De Cancerologia De Mèxico, Mexico City, Mexico.
  • AFINES program, Medicine Faculty, National Autonomous University of Mexico (UNAM), Coyoacan, Mexico City, Mexico.
  • Hospital Angeles Tijuana, Tijuana, Baja California Norte, Mexico.

Zitieren

APA

Saul Lino-Silva, L., Galán-Ramírez, Á., Martínez-Villavicencio, S. B., Rivera-Moncada, L., Zepeda-Najar, C., & Ortega-Martínez, H. I. (2025). Assessment of the status of DNA mismatch repair proteins by immunohistochemistry. Proposal for evaluation with two antibodies. Polish Journal of Pathology, 76(1), 54-58. https://doi.org/10.5114/pjp.2025.148390

Vancouver

Saul Lino-Silva L, Galán-Ramírez Á, Martínez-Villavicencio SB, Rivera-Moncada L, Zepeda-Najar C, Ortega-Martínez HI. Assessment of the status of DNA mismatch repair proteins by immunohistochemistry. Proposal for evaluation with two antibodies. Polish Journal of Pathology. 2025;76(1):54-58. doi:10.5114/pjp.2025.148390

BibTeX
@article{SaulLinoSilva2025,
  author = {Saul Lino-Silva, Leonardo and Galán-Ramírez, Ángeles and Martínez-Villavicencio, Sabrina B and Rivera-Moncada, Luisa and Zepeda-Najar, César and Ortega-Martínez, Hanna I},
  title = {Assessment of the status of DNA mismatch repair proteins by immunohistochemistry. Proposal for evaluation with two antibodies},
  journal = {Polish Journal of Pathology},
  year = {2025},
  volume = {76},
  number = {1},
  pages = {54--58},
  doi = {10.5114/pjp.2025.148390}
}
Kostenlos starten →